Investing at the intersection of the microbiome and cancer to transform patient outcomes

Xsensio develops the unique Lab-on-Skin™​ sensing platform to sense in real-time biochemical information at the surface of the skin, providing unprecedented real-time information about our health and wellness, in a simple and non-invasive way. The Xsensio Lab-on-Skin™ sensing chip relies on a unique, highly-miniaturized sensing platform. By leveraging semiconductor properties, our sensing platform unleashes a whole new set of possibilities in continuous health monitoring.

Based on a novel biosensing approach called the “Molecular Pendulum”, Arma Bioscience has developed a rapid, versatile sensor platform to enable continuous monitoring of a multitude of physiological markers. The Arma platform’s sensing tips are compatible with saliva, blood, urine, sweat, and tears, and can be quickly developed to detect for various health indications. Seerave placed a seed investment into Arma Biosceince with the conviction that their expertise around label-free biosensor technology could be key in enabling wearable biosensors in the future.

Based in Cambridge, UK, Abselion creates technologies that simplify biological measurements across life sciences, biotech, and therapeutic development. Their platform combines robust engineering, purpose-built assay formats, and intuitive software to streamline workflows and enable faster, more confident decisions – delivering high-quality data without the cost and complexity of traditional systems.

Florey Biosciences is a Boston-based biotechnology company that uses synthetic biology to create and improve beneficial micro-organisms for human health.

BiomeSense has created the first technology to overhaul microbiome data generation & analysis (1) GutLab At-home Automated Laboratory – The GutLab is a proprietary “smart bathroom” technology for microbiome tracking, combining a user-friendly interface and advanced internal fluidics to produce high-frequency, fully standardized data (2) MetaBiome Bioinformatics Platform – MetaBiome is an AI-powered microbiome biomarker discovery engine, designed by Rob Knight @ UCSD, that uses advanced signal processing algorithms to enable microbiome analysis far beyond anything possible today In an industry first, these solutions form a single comprehensive platform – the GutLab continuously feeds ultra-high-resolution data into MetaBiome’s database where it is analyzed using MetaBiome AI. This platform generates far superior microbiome data than ever before possible, revolutionizing the development of microbiome biomarkers, precision therapeutics, and consumer products.